Landscapes / Companies
Advanced Accelerator Applications not checked
FollowEvery new trial, moved date and filing, and a Monday email
Next date
None yet
Drugs
1
in active trials · 6 in all
Trials
2 active
6 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Novartis |
Approved | — | ||
| Also tested for | Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma and 1 more | ||||
| Open drug page | |||||
About
- No active trial
- -NeoB, 177Lu-DOTA0-Tyr3-Octreotate, 177Lu-PSMA-R2, arginine/lysine, LCZ696
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021